Search research articles
Contact Us
Filters
Showing results (271-280 of 278) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 278 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
Marco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.
Nature Medicine
|
December 18, 2021
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, et al.
Blood
|
January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
The New England Journal of Medicine
|
December 14, 2021
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
Michael R Bishop, Michael Dickinson, Duncan Purtill, et al.
Haematologica
|
April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study
Marie José Kersten, Martin Dreyling, Kim M Linton, et al.
Blood
|
June 2, 2022
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elias Campo, Elaine S Jaffe, James R Cook, et al.
Blood
|
August 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 278) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 278 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
Marco Ladetto, Katja Gutmair, Rita Tavarozzi, et al.
Nature Medicine
|
December 18, 2021
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, et al.
Blood
|
January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
The New England Journal of Medicine
|
December 14, 2021
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
Michael R Bishop, Michael Dickinson, Duncan Purtill, et al.
Haematologica
|
April 16, 2026
Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study
Marie José Kersten, Martin Dreyling, Kim M Linton, et al.
Blood
|
June 2, 2022
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elias Campo, Elaine S Jaffe, James R Cook, et al.
Blood
|
August 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.
Page
of 28